These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12446233)

  • 1. [Maternal serum screening for Down's syndrome].
    Muller F
    Ann Biol Clin (Paris); 2002; 60(6):689-92. PubMed ID: 12446233
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of effect of analytical imprecision in maternal serum screening for Down's syndrome.
    Spencer K
    Ann Clin Biochem; 2001 Jul; 38(Pt 4):413-4. PubMed ID: 11471889
    [No Abstract]   [Full Text] [Related]  

  • 3. [Screening by maternal serum markers for Down's syndrome].
    Liu JT; Hao N; Sun NH; Wang FY; Xu YH; Gai MY; Bian XM; Yang JQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):156-9. PubMed ID: 12905710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prenatal diagnosis of Down's syndrome: prediction from maternal serum markers].
    Zilberstein T; Maymon E
    Harefuah; 1998 Mar; 134(5):393-6. PubMed ID: 10909560
    [No Abstract]   [Full Text] [Related]  

  • 5. First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free beta-hCG and pregnancy-associated plasma protein-A assays.
    Spencer K
    Ann Clin Biochem; 2005 Jan; 42(Pt 1):30-40. PubMed ID: 15802030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases.
    Marsk A; Grunewald C; Saltvedt S; Valentin L; Almström H
    Acta Obstet Gynecol Scand; 2006; 85(5):534-8. PubMed ID: 16752230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First trimester predictors of adverse pregnancy outcomes.
    Brameld KJ; Dickinson JE; O'Leary P; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R
    Aust N Z J Obstet Gynaecol; 2008 Dec; 48(6):529-35. PubMed ID: 19133038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Kagan KO; Wright D; Maiz N; Pandeva I; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Sep; 32(4):488-92. PubMed ID: 18726925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy outcomes in unselected singleton pregnant women with an increased risk of first-trimester Down's syndrome.
    Liu SS; Lee FK; Lee JL; Tsai MS; Cheong ML; She BQ; Chen SC
    Acta Obstet Gynecol Scand; 2004 Dec; 83(12):1130-4. PubMed ID: 15548144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First trimester Down's syndrome screening marker values and cigarette smoking: new data and a meta-analysis on free beta human chorionic gonadotophin, pregnancy-associated plasma protein-A and nuchal translucency.
    Bestwick JP; Huttly WJ; Wald NJ
    J Med Screen; 2008; 15(4):204-6. PubMed ID: 19106261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prenatal screening for Down's syndrome].
    Qin Q; Christiansen M; Norgaard-Pedersen B
    Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):694-7. PubMed ID: 9639772
    [No Abstract]   [Full Text] [Related]  

  • 12. First and second-trimester biochemical markers of chromosomal anomalies and their relationship to maternal haemoglobin levels.
    Cowans NJ; Spencer K
    Prenat Diagn; 2005 Aug; 25(8):693-9. PubMed ID: 16050001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for fetal aneuploidy: is maternal age relevant?
    Hawk AF; Saller DN
    Clin Obstet Gynecol; 2012 Mar; 55(1):217-25. PubMed ID: 22343240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of temperature on free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A concentration.
    Cruz J; Cruz G; Minekawa R; Maiz N; Nicolaides KH
    Ultrasound Obstet Gynecol; 2010 Aug; 36(2):141-6. PubMed ID: 20503238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibin A is a maternal serum marker for Down's syndrome early in the first trimester.
    Christiansen M; Nørgaard-Pedersen B
    Clin Genet; 2005 Jul; 68(1):35-9. PubMed ID: 15952984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First trimester screening for Down's syndrome after assisted reproductive technology: non-male factor infertility is associated with elevated free beta-human chorionic gonadotropin levels at 10-14 weeks of gestation.
    Anckaert E; Schiettecatte J; Sleurs E; Devroey P; Smitz J
    Fertil Steril; 2008 Oct; 90(4):1206-10. PubMed ID: 18164000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of first trimester Down syndrome screening studies: free beta-human chorionic gonadotropin significantly outperforms intact human chorionic gonadotropin in a multimarker protocol.
    Evans MI; Krantz DA; Hallahan TW; Galen RS
    Am J Obstet Gynecol; 2007 Mar; 196(3):198-205. PubMed ID: 17346522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down syndrome screening marker levels in women with a previous aneuploidy pregnancy.
    Cuckle HS; Spencer K; Nicolaides KH
    Prenat Diagn; 2005 Jan; 25(1):47-50. PubMed ID: 15662693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect on Down syndrome screening performance of adjusting for marker levels in a previous pregnancy.
    Wald NJ; Barnes IM; Birger R; Huttly W
    Prenat Diagn; 2006 Jun; 26(6):539-44. PubMed ID: 16634123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down's syndrome risk estimates demonstrate considerable heterogeneity despite homogeneity of input.
    Reynolds T; Ellis A; Jones R
    Ann Clin Biochem; 2004 Nov; 41(Pt 6):464-8. PubMed ID: 15588435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.